NCT00171392View on ClinicalTrials.gov

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Prevention of Acute Rejection After Kidney Transplantation
Interventions
DRUG

Enteric-coated mycophenolate sodium

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171392 - Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus | Biotech Hunter | Biotech Hunter